세계의 동물 진단 시장 : 제품별, 용도별, 기술별, 동물 유형별, 유통 채널별, 최종 사용자별, 지역별, 미충족 수요, 구매 기준별 예측(-2029년)

Veterinary Diagnostic Market by Product (Instrument, Consumable), Technology (Immuno (ELISA, RIA, Lateral flow), Molecular (PCR, Microarray), Hematology, Imaging), Distribution Channel, End User, Unmet Need, Buying Criteria - Global Forecast to 2029

US $ 4,950 ￦ 6,786,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,117,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,174,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,711,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

조사 범위
조사 대상년도	2021년-2029년
기준년도	2022년
예측 기간	2023년-2029년
검토 단위	10억 달러
부문	제품 유형별, 용도별, 기술별, 동물 유형별, 유통 채널별, 최종 사용자별, 지역별
대상지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동/아프리카

동물 진단 시장 규모는 2023년 33억 달러에 달할 것으로 예상되며, 향후 7.1%의 CAGR로 확대되어 2029년에는 50억 달러에 달할 것으로 전망됩니다.

동물 진단 시장은 주로 개, 고양이 등 반려동물 증가, 반려동물 보험 증가, 세계 동물 의료비 지출 증가, 신흥국의 동물 건강에 대한 보급 및 인식 개선, 동물 기생충 감염 증가 등의 영향을 받고 있습니다.

동물 진단에는 주로 진단 테스트 분석기와 휴대용 분석기가 포함됩니다. 이들 분석기는 동물의 체액(혈액, 혈청, 혈장, 소변) 및 분변에 포함된 생리적으로 중요한 물질을 측정합니다. 진단 검사 분석기에는 임상화학 분석기, 포도당 모니터, 혈액가스 전해질 분석기, 소변 분석기, 혈액학 분석기, 측면 흐름 스트립 판독기, 면역 진단 분석기 등이 있습니다. 주요 제조업체는 분석기와 질병 진단에 사용되는 시약 클립, 카트리지, 패널 및 키트를 별도로 제공합니다. 기술 발전 증가와 장비에 AI 도구의 통합은 이 시장의 성장에 영향을 미치는 요인으로 작용하고 있습니다.

임상 생화학은 기술별 시장에서 두 번째로 큰 점유율을 차지했습니다. 이는 작은 동물의 감염 및 대사 장애를 선별하는 데 사용되는 중요한 기술입니다. 신장 기능, 당뇨병, 전해질 및 호르몬 평가, 간 기능 연구, 박테리아, 바이러스, 기생충과 같은 감염성 요인으로 인한 전신 염증에 이르기까지 다양한 질병과 장애를 평가할 수 있습니다. 임상 생화학 분석기는 동물 진단 실험실에서 더 널리 사용되고 있으며, 이는 동물 진단 시장에서 높은 점유율을 차지하고 있습니다. 포도당 검사 건수가 많습니다. 임상 검사, 전해질 검사가 시장에 영향을 미치고 있습니다.

예측 기간 동안 아시아태평양은 가장 빠른 속도로 성장할 것으로 예상됩니다. 이 지역의 동물 진단 시장의 성장을 가속하는 주요 요인은 동물 건강에 대한 인식, 1인당 소득 증가, 반려동물 사육을 늘리기 위한 정부의 이니셔티브, 특히 중국과 인도의 축산물 생산 증가, 동물 질병 증가 등입니다.

이 보고서는 세계 동물 진단 시장을 조사했으며, 제품별/용도별/기술별/동물 유형별/유통 채널별/최종 사용자별/지역별 동향, 시장 진출기업 프로파일 등을 정리하였습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 시장 역학
• 업계 동향
• 병 동향
• 기술 분석
• 가격 분석
• 밸류체인 분석
• 생태계/시장 맵
• Porter의 Five Forces 분석
• 공급망 분석
• 관세 및 규제 상황
• 특허 분석
• 주요 컨퍼런스 및 이벤트(2023년-2025년)
• 주요 이해관계자와 구입 기준
• 무역 분석
• 사례 연구
• 인접하는 시장
• 최종사용자의 견해와 만 싶음 미충족 요구
• 수의학 진단 AI 통합

제6장 동물 진단 시장, 제품별

• 서론
• 소모품
• 장비

제7장 동물 진단 시장, 기술별

• 서론
• 면역진단
• 임상 생화학
• 분자진단
• 소변검사
• 혈액학
• 기타

제8장 동물 진단 시장, 동물 유형별

• 서론
• 반려동물
• 가축

제9장 동물 진단 시장, 용도별

• 서론
• 감염증
• 내분비학
• 심장병
• 종양학
• 기타

제10장 동물 진단 시장, 유통 채널별

• 서론
• 직접 판매
• 도매업체와 판매업체
• 온라인 판매 플랫폼

제11장 동물 진단 시장, 최종사용자별

• 서론
• 수의 기준 연구소
• 동물 병원 및 진료소
• POC/사내 테스트
• 수의학 조사기관 및 대학

제12장 동물 진단 시장, 지역별

• 서론
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제13장 경쟁 구도

• 개요
• 주요 시장 진출기업의 전략/유력 기업
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 신규 기업/중소기업 평가 매트릭스
• 경쟁 시나리오

제14장 기업 개요

• 주요 시장 진출기업
  • IDEXX LABORATORIES, INC.
  • ZOETIS, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • HESKA CORPORATION(MARS INCORPORATED)
  • BIOMERIEUX SA
  • NEOGEN CORPORATION
  • BIO-RAD LABORATORIES, INC.
  • VIRBAC
  • FUJIFILM HOLDINGS CORPORATION
  • SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
  • INDICAL BIOSCIENCE GMBH
  • BIONOTE INC.
  • BIOGAL GALED LABS
  • AGROLABO S.P.A.
  • INNOVATIVE DIAGNOSTICS
• 기타 기업
  • RANDOX LABORATORIES LTD.
  • BIOCHEK
  • FASSISI GMBH
  • ALVEDIA
  • SKYER, INC.
  • SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
  • PRECISION BIOSENSOR
  • EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
  • GOLD STANDARD DIAGNOSTICS
  • ANTECH DIAGNOSTICS, INC.

제15장 부록

LSH

영문 목차

영문목차

Report Description

Scope of the Report
Years Considered for the Study	2021-2029
Base Year	2022
Forecast Period	2023-2029
Units Considered	Value (USD) Billion
Segments	By product, application, technology, animal type, distribution channel, end user and region
Regions covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The veterinary diagnostics market is valued at an estimated USD 3.3 billion in 2023 and is projected to reach USD 5.0 billion by 2029, at a CAGR of 7.1% during the forecast period. The veterinary diagnostics market is influenced mainly by the rise in animals such as dogs and cats, increase in the insurance for companion animals, global animal healthcare expenditure, increased adoption and awareness about animal health in emerging economies, rise in parasitic infections in animals, etc.

"The instruments segment is projected to have the highest growth in this market."

Veterinary diagnostic instruments mainly include diagnostic test analyzers and portable analyzers. These analyzers measure the physiologically significant substances present in body fluids (blood, serum, plasma, and urine) and feces of animals. Diagnostic test analyzers include clinical chemistry analyzers, glucose monitors, blood gas-electrolyte analyzers, urine analyzers, hematology analyzers, lateral flow strip readers, and immunodiagnostic analyzers. Major market players offer analyzers separately, along with reagent clips, cartridges, panels, and kits used in disease diagnosis. Increasing technological advancement and the incorporation of AI tools in instruments are factors influencing its growth.

"Clinical Biochemistry segment accounted for the largest share after immunodiagnostics in the technology segment."

Clinical biochemistry accounted for the second largest share in the technology market. It is an important technology used for screening infectious and metabolic disorders in small animals. Diseases and disorders evaluated using this technology can range from studying kidney function, diabetes, electrolyte & hormone evaluation, and liver function to systemic inflammation caused by infectious agents such as bacteria, viruses, and parasites. Clinical biochemistry analyzers are more widely adopted in veterinary diagnostics laboratories, which leads to a higher share in the veterinary diagnostics market. Large number of cases of glucose testing. Clinical testing, and electrolyte testing have influenced the market.

"Asia Pacific market to witness the highest growth during the forecast period."

During the forecast period, APAC is anticipated to grow at the fastest rate. The major factors promoting the growth of the veterinary diagnostics market in this region are awareness about animal health, growing per capita income, government initiative for increasing adoption of pets, rise in production of livestock products, especially by China and India, and increase in diseases among animals.

A breakdown of the primary participants (supply-side) for the veterinary diagnostics market referred to for this report is provided below:

a

• By Company Type: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
• By Designation: C-level Executives: 23%, Directors: 30%, and Others: 47%
• By Region: North America: 33%, Europe: 20%, Asia Pacific: 28%, Latin America: 13%; Middle East and Africa: 59%;

The prominent players operating in the veterinary diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific Inc. (US), bioMerieux SA (France), Heska Corporation (US), NEOGEN Corporation (US), Bio-Rad Laboratories Inc. (US), Virbac (France), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Animal Medical Technology Co. Ltd. (China), INDICAL BIOSCIENCE GmbH (Germany), BioNote, Inc. (South Korea), Biogal Galed Labs (Israel), Agrolabo S.p.A. (Italy), Innovative Diagnostics (France), Randox Laboratories Ltd. (Ireland), BioChek (Netherlands), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), Gold Standard Diagnostics (Germany), Precision Biosensor Inc. (South Korea), Antech Diagnsotics Inc. (US), and EUROIMMUN Medizinische Labordiagnostika AG (Germany).

Research Coverage:

The market study covers the veterinary diagnostics market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product, application, technology, distribution channel, animal type, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall veterinary diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (Rise in companion animals, growing demand for products derived from animals, increased zoonotic disease cases, increase in pet insurance, increase in disease control and disease prevention measures), restraints (Rising pet cost care and high cost of diagnostic tests), opportunities (untapped emerging market) and challenges (lack fo animal health awareness, and shortage of veterinary practitioners) influencing the growth of the veterinary diagnostics market
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary diagnostics market. The report analyzes this market by type of product, application, technology, animal type, distribution channel, end-user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global veterinary diagnostics market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product, application, technology, animal type, distribution channel, end-user, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global veterinary diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global veterinary diagnostics market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
  • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
  • FIGURE 7 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES: VETERINARY DIAGNOSTICS MARKET (2022)
  • FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2023-2029)
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 10 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
• 2.4 MARKET SHARE ANALYSIS
• 2.5 ASSUMPTIONS
• 2.6 LIMITATIONS
• 2.7 RISK ASSESSMENT
  • TABLE 1 RISK ASSESSMENT: VETERINARY DIAGNOSTICS MARKET
• 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 12 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION)
• FIGURE 13 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023 VS. 2029 (USD MILLION)
• FIGURE 14 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023 VS. 2029 (USD MILLION)
• FIGURE 15 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
• FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2029 (USD MILLION)
• FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
• FIGURE 18 GEOGRAPHICAL SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET

4 PREMIUM INSIGHTS

• 4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW
  • FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH
• 4.2 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2022)
  • FIGURE 20 VETERINARY REFERENCE LABORATORIES ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022
• 4.3 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
• 4.4 VETERINARY DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
  • FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 MARKET DYNAMICS
  • FIGURE 23 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.1.1 DRIVERS
    • 5.1.1.1 Growth in companion animal population
  • TABLE 2 NUMBER OF US HOUSEHOLDS THAT OWN A PET, BY ANIMAL TYPE (MILLIONS)
  • TABLE 3 PET POPULATION, BY ANIMAL, 2014-2022 (MILLION)
    • 5.1.1.2 Rising demand for animal-derived food products
  • FIGURE 24 MAJOR PRODUCERS OF COW MILK WORLDWIDE IN 2022, BY COUNTRY (MILLION METRIC TONS)
  • TABLE 4 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES
  • TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
    • 5.1.1.3 Increasing incidence of transboundary and zoonotic diseases
  • TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009-2023)
    • 5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
  • TABLE 8 US: AVERAGE ANNUAL PREMIUMS PAID (2020-2022)
  • FIGURE 25 US VS CANADA: GROSS WRITTEN PREMIUMS FOR DOGS, 2020-2022 (IN USD MILLION)
  • FIGURE 26 US VS CANADA: GROSS WRITTEN PREMIUMS FOR CATS, 2020-2022 (IN USD MILLION)
  • FIGURE 27 US: PET INDUSTRY EXPENDITURE, 2010-2022
  • TABLE 9 US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020-2022 (USD BILLION)
  • TABLE 10 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012-2022 (USD MILLION)
    • 5.1.1.5 Growing number of veterinary practitioners and rising income levels in developed economies
  • TABLE 11 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012-2020
    • 5.1.1.6 Increasing disease control and prevention measures
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 Rising pet care costs
  • FIGURE 28 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2022
    • 5.1.2.2 High cost of veterinary diagnostic tests
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Untapped emerging markets
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Lack of animal healthcare awareness in emerging countries
    • 5.1.4.2 Shortage of veterinary practitioners in emerging economies
  • TABLE 12 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS 2014 VS 2018
• 5.2 INDUSTRY TRENDS
  • 5.2.1 ADOPTION OF MULTIPLE TEST PANELS
  • TABLE 13 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS
  • 5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
  • 5.2.3 GROWING CONSOLIDATION IN VETERINARY DIAGNOSTICS INDUSTRY
  • TABLE 14 MAJOR ACQUISITIONS IN ANIMAL HEALTH DIAGNOSTICS INDUSTRY
  • 5.2.4 GROWING SCALE OF VETERINARY BUSINESSES
• 5.3 DISEASE TRENDS
  • 5.3.1 LIVESTOCK
    • 5.3.1.1 Avian Influenza
    • 5.3.1.2 African Swine Fever
    • 5.3.1.3 Bovine Babesiosis
    • 5.3.1.4 Peste des Petits Ruminants
    • 5.3.1.5 West Nile Virus
  • 5.3.2 COMPANION ANIMALS
    • 5.3.2.1 Zoonotic diseases
  • TABLE 15 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS
    • 5.3.2.2 Obesity & diabetes
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Portable instruments for POC diagnostic services
  • TABLE 16 POC PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS AND MANUFACTURERS
  • 5.4.2 ADJACENT TECHNOLOGIES
    • 5.4.2.1 Rapid and sensitive veterinary diagnostic kits
  • 5.4.3 COMPLEMENTARY TECHNOLOGIES
• 5.5 PRICING ANALYSIS
  • TABLE 17 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2022 (USD)
  • 5.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION
  • TABLE 18 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP 3 APPLICATIONS (USD)
  • 5.5.2 AVERAGE SELLING PRICE TRENDS, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
  • FIGURE 29 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM/MARKET MAP
  • FIGURE 30 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 19 VETERINARY DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 THREAT OF NEW ENTRANTS
  • 5.8.2 THREAT OF SUBSTITUTES
  • 5.8.3 BARGAINING POWER OF SUPPLIERS
  • 5.8.4 BARGAINING POWER OF BUYERS
  • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.9 SUPPLY CHAIN ANALYSIS
  • FIGURE 31 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
• 5.10 TARIFF AND REGULATORY LANDSCAPE
  • 5.10.1 REGULATORY ANALYSIS
    • 5.10.1.1 US
    • 5.10.1.2 Europe
    • 5.10.1.3 Rest of the world
  • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2.1 North America
  • TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2.2 Europe
  • TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2.3 Rest of the world
  • TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
  • FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2013-OCTOBER 2023)
  • 5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS
  • FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013-OCTOBER 2023)
  • FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013-OCTOBER 2023)
• 5.12 KEY CONFERENCES AND EVENTS (2023-2025)
  • TABLE 23 VETERINARY DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS
  • 5.13.2 BUYING CRITERIA
  • FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 25 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
• 5.14 TRADE ANALYSIS
  • TABLE 26 TOP EXPORTERS OF VETERINARY DIAGNOSTIC CONSUMABLES (REAGENTS; COMPOSITE DIAGNOSTIC OR LABORATORY), 2022
• 5.15 CASE STUDIES
  • TABLE 27 INCREASE IN PATIENT VISITS AND DIAGNOSTIC PROCEDURES
  • TABLE 28 UNMET CUSTOMER NEEDS IN LIVESTOCK DIAGNOSTICS MARKET
  • TABLE 29 OPPORTUNITY ASSESSMENT IN HIGH-END AUTOMATED IMMUNOASSAY ANALYZERS IN COMPANION ANIMAL IMMUNODIAGNOSTICS
  • TABLE 30 IDENTIFICATION OF INTESTINAL PARASITE
• 5.16 ADJACENT MARKETS
  • FIGURE 37 VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS
• 5.17 END-USER PERSPECTIVE & UNMET NEEDS
• 5.18 AI INTEGRATION IN VETERINARY DIAGNOSTICS

6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 31 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• 6.2 CONSUMABLES
  • 6.2.1 CONSUMABLES TO HOLD LARGEST SHARE OF PRODUCTS MARKET
  • TABLE 32 KEY VETERINARY DIAGNOSTIC CONSUMABLES, BY COMPANY (2022)
  • TABLE 33 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 6.3 INSTRUMENTS
  • 6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET
  • TABLE 34 KEY VETERINARY DIAGNOSTIC INSTRUMENTS, BY COMPANY (2022)
  • TABLE 35 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)

7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
  • TABLE 36 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
• 7.2 IMMUNODIAGNOSTICS
  • TABLE 37 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS, BY COMPANY
  • TABLE 38 VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 39 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.1 LATERAL FLOW ASSAYS
  • TABLE 40 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 41 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.1 Lateral flow rapid tests
      • 7.2.1.1.1 Lateral flow rapid tests to dominate market
  • TABLE 42 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.2.1.2 Lateral flow strip readers
      • 7.2.1.2.1 Rising need for readers to determine analyte quantity to drive adoption
  • TABLE 43 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.2 ELISA
    • 7.2.2.1 Cost-effectiveness and ease of use to drive demand
  • TABLE 44 ELISA MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
    • 7.2.3.1 Increasing incidence of allergies in companion animals to drive market growth
  • TABLE 45 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.4 IMMUNOASSAY ANALYZERS
    • 7.2.4.1 Growing use of immunoassay analyzers for livestock to propel market
  • TABLE 46 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.5 RADIOIMMUNOASSAYS
    • 7.2.5.1 Growing importance, high sensitivity & specificity to drive market
  • TABLE 47 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.2.6 OTHER IMMUNODIAGNOSTIC PRODUCTS
  • TABLE 48 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.3 CLINICAL BIOCHEMISTRY
  • TABLE 49 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS, BY COMPANY
  • TABLE 50 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 51 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.3.1 CLINICAL CHEMISTRY ANALYSIS
  • TABLE 52 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 53 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.3.1.1 Clinical chemistry reagent clips & cartridges
      • 7.3.1.1.1 Rising number of screening tests performed to drive market
  • TABLE 54 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.3.1.2 Clinical chemistry analyzers
      • 7.3.1.2.1 Increasing installations of clinical chemistry analyzers to propel growth
  • TABLE 55 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.3.2 GLUCOSE MONITORING
  • TABLE 56 GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 57 GLUCOSE MONITORING MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.3.2.1 Blood glucose strips
      • 7.3.2.1.1 Growing demand for blood glucose strips in home care settings to drive market
  • TABLE 58 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.3.2.2 Glucose monitors
      • 7.3.2.2.1 Growing incidence of diabetes in pet animals to drive adoption of glucose monitors
  • TABLE 59 GLUCOSE MONITORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.3.2.3 Urine glucose strips
      • 7.3.2.3.1 Growing risk of DKA in animals to drive market
  • TABLE 60 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.3.3 BLOOD GAS & ELECTROLYTE ANALYSIS
  • TABLE 61 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 62 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.3.3.1 Blood gas & electrolyte reagent clips & cartridges
      • 7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to boost market growth
  • TABLE 63 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • 7.3.3.2 Blood gas & electrolyte analyzers
      • 7.3.3.2.1 Growing adoption of analyzers to determine oxygen and carbon dioxide levels in blood to drive market
  • TABLE 64 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.4 MOLECULAR DIAGNOSTICS
  • TABLE 65 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 66 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.4.1 PCR TESTS
    • 7.4.1.1 Increased laboratory usage of PCR in proteomics and genomics to support growth
  • TABLE 67 PCR TESTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.4.2 MICROARRAYS
    • 7.4.2.1 Growing applications of biochips in identifying infectious diseases to propel market
  • TABLE 68 MICROARRAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.4.3 NUCLEIC ACID SEQUENCING
    • 7.4.3.1 Increased application of nucleic acid sequencing in diagnosis to drive market
  • TABLE 69 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.4.4 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
  • TABLE 70 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.5 URINALYSIS
  • TABLE 71 KEY VETERINARY URINALYSIS PRODUCTS, BY COMPANY
  • TABLE 72 VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 73 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.5.1 URINALYSIS CLIPS & CARTRIDGES/PANELS
    • 7.5.1.1 Growing use of clips and cartridges in urine analyzers to detect electrolytes to drive market
  • TABLE 74 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.5.2 URINE ANALYZERS
    • 7.5.2.1 Development of easy-to-use urine analyzers for POC testing to drive market
  • TABLE 75 URINE ANALYZERS MARKET, BY COUNTRY, 2021-2029 USD MILLION)
  • 7.5.3 URINE TEST STRIPS
    • 7.5.3.1 Rising occurrence of kidney diseases in cats and dogs to support market
  • TABLE 76 URINE TEST STRIPS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.6 HEMATOLOGY
  • TABLE 77 KEY VETERINARY HEMATOLOGY PRODUCTS, BY COMPANY
  • TABLE 78 VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 79 VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.6.1 HEMATOLOGY CARTRIDGES
    • 7.6.1.1 Extensive use of hematology cartridges along with hematology analyzers for complete blood analysis to fuel growth
  • TABLE 80 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • 7.6.2 HEMATOLOGY ANALYZERS
    • 7.6.2.1 High usage of hematology analyzers by veterinary hospitals & clinics to support growth
  • TABLE 81 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
• 7.7 OTHER TECHNOLOGIES
  • TABLE 82 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)

8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE

• 8.1 INTRODUCTION
  • TABLE 83 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
• 8.2 COMPANION ANIMALS
  • TABLE 84 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 85 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 86 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.2.1 DOGS
    • 8.2.1.1 High insurance coverage for dogs to drive market
  • TABLE 87 CANINE POPULATION, BY COUNTRY, 2014-2022 (MILLION)
  • TABLE 88 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.2.2 CATS
    • 8.2.2.1 Growing pet cat population to support growth
  • TABLE 89 FELINE POPULATION, BY COUNTRY, 2012-2020 (MILLION)
  • TABLE 90 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.2.3 HORSES
    • 8.2.3.1 Growing equine health awareness to drive market
  • FIGURE 38 US: NUMBER OF PRIVATE EQUINE CLINICAL PRACTICES, 2009-2022
  • TABLE 91 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.2.4 OTHER COMPANION ANIMALS
  • TABLE 92 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2021-2029 (USD MILLION)
• 8.3 LIVESTOCK
  • TABLE 93 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 94 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 95 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3.1 CATTLE
    • 8.3.1.1 Growing consumption of meat to support market growth
  • FIGURE 39 MEAT PRODUCTION, BY TYPE, 2021-2022 (MILLION TONS)
  • FIGURE 40 MILK PRODUCTION, BY REGION, 2021-2022 (MILLION TONS)
  • TABLE 96 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3.2 PIGS
    • 8.3.2.1 Growing incidence of infectious diseases to drive market
  • FIGURE 41 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, EMERGING ECONOMIES VS. DEVELOPED COUNTRIES, 2020-2030
  • TABLE 97 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3.3 POULTRY
    • 8.3.3.1 Increasing demand for poultry meat to contribute to market growth
  • TABLE 98 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3.4 OTHER LIVESTOCK
  • TABLE 99 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2021-2029 (USD MILLION)

9 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION

• 9.1 INTRODUCTION
  • TABLE 100 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• 9.2 INFECTIOUS DISEASES
  • TABLE 101 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 102 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2029 (USD MILLION)
  • 9.2.1 BACTERIAL INFECTIONS
    • 9.2.1.1 Bacterial infections to hold largest share of infectious disease diagnostics
  • TABLE 103 VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 9.2.2 VIRAL INFECTIONS
    • 9.2.2.1 High mutation rate to ensure continued demand for diagnostics
  • TABLE 104 VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 9.2.3 PARASITIC INFECTIONS
    • 9.2.3.1 High prevalence of parasitic infections to propel demand
  • TABLE 105 VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 9.2.4 OTHER INFECTIONS
  • TABLE 106 VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
• 9.3 ENDOCRINOLOGY
  • 9.3.1 GROWING RISK OF DIABETES TO SUPPORT DEMAND
  • TABLE 107 VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2021-2029 (USD MILLION)
• 9.4 CARDIOLOGY
  • 9.4.1 RISING INCIDENCE OF CARDIAC DISEASES IN DOGS TO DRIVE MARKET
  • TABLE 108 VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021-2029 (USD MILLION)
• 9.5 ONCOLOGY
  • 9.5.1 HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET
  • TABLE 109 VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2029 (USD MILLION)
• 9.6 OTHER APPLICATIONS
  • TABLE 110 VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)

10 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL

• 10.1 INTRODUCTION
  • TABLE 111 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
• 10.2 DIRECT SALES
  • 10.2.1 DIRECT SALES TO HOLD LARGEST MARKET SHARE
  • TABLE 112 VETERINARY DIAGNOSTICS MARKET FOR DIRECT SALES, BY COUNTRY, 2021-2029 (USD MILLION)
• 10.3 WHOLESALERS & DISTRIBUTORS
  • 10.3.1 GROWING VOLUME OF INTERNATIONAL SALES TO SUPPORT SEGMENT GROWTH
  • TABLE 113 VETERINARY DIAGNOSTICS MARKET FOR WHOLESALERS & DISTRIBUTORS, BY COUNTRY, 2021-2029 (USD MILLION)
• 10.4 ONLINE SALES PLATFORMS
  • 10.4.1 ONLINE SALES TO SEE HIGHEST GROWTH
  • TABLE 114 VETERINARY DIAGNOSTICS MARKET FOR ONLINE SALES PLATFORMS, BY COUNTRY, 2021-2029 (USD MILLION)

11 VETERINARY DIAGNOSTICS MARKET, BY END USER

• 11.1 INTRODUCTION
  • TABLE 115 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 11.2 VETERINARY REFERENCE LABORATORIES
  • 11.2.1 LARGE VOLUME OF SAMPLES RECEIVED BY VETERINARY REFERENCE LABORATORIES TO DRIVE MARKET GROWTH
  • TABLE 116 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2021-2029 (USD MILLION)
• 11.3 VETERINARY HOSPITALS & CLINICS
  • 11.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET
  • FIGURE 42 US: VETERINARIAN CLINICAL PRACTICES, BY TYPE, 2022
  • TABLE 117 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2021-2029 (USD MILLION)
• 11.4 POC/IN-HOUSE TESTING
  • 11.4.1 EASE OF USE, COST-EFFECTIVENESS, AND SWIFT RESULTS OFFERED BY POINT-OF-CARE TESTS TO DRIVE DEMAND
  • TABLE 118 VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
• 11.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
  • 11.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES TO SUPPORT GROWTH
  • TABLE 119 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2021-2029 (USD MILLION)

12 VETERINARY DIAGNOSTICS MARKET, BY REGION

• 12.1 INTRODUCTION
  • TABLE 120 VETERINARY DIAGNOSTICS MARKET, BY REGION, 2021-2029 (USD MILLION)
• 12.2 NORTH AMERICA
  • FIGURE 43 NORTH AMERICA: PROJECTED GROWTH IN NUMBER OF VETERINARIANS
  • 12.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 44 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
  • TABLE 121 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 133 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 136 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 138 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 139 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.2.2 US
    • 12.2.2.1 US to dominate North American market during forecast period
  • FIGURE 45 US: POPULATION OF DOGS, 2012-2022 (MILLION)
  • FIGURE 46 US: EXPENDITURE ON VET VISITS, 2013-2021
  • TABLE 140 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020 VS 2021
  • FIGURE 47 US: VETERINARIAN INCOME LEVELS, 2017-2022
  • FIGURE 48 US: NUMBER OF VETERINARIANS, 2016-2021
  • TABLE 141 US: FOOD-PRODUCING ANIMAL POPULATION, 2001-2019 (MILLION)
  • TABLE 142 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014-2020
  • TABLE 143 US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 144 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 145 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 146 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 147 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 148 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 149 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 150 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 151 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 152 US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 153 US: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 154 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 155 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 156 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 157 US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 158 US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 159 US: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 160 US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.2.3 CANADA
    • 12.2.3.1 Growing pet adoption in Canada to drive market growth
  • FIGURE 49 CANADA: COMPANION ANIMAL POPULATION, 2020-2022 (MILLION)
  • TABLE 161 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 162 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 163 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 164 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 165 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 166 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 167 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 168 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 169 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 170 CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 171 CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 172 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 173 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 174 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 175 CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 176 CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 177 CANADA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 178 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.3 EUROPE
  • TABLE 179 EUROPE: COMPANION POPULATION, 2022 (MILLION)
  • 12.3.1 EUROPE: RECESSION IMPACT
  • TABLE 180 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 181 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 182 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 183 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 184 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 185 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 186 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 187 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 188 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 189 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 190 EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 191 EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 192 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 193 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 194 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 195 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 196 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 197 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 198 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)

• 12.3.2 GERMANY
  • 12.3.2.1 Rising awareness of zoonotic diseases to drive market growth
• TABLE 199 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 200 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
• TABLE 201 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 202 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 203 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 204 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 205 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 206 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 207 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 208 GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 209 GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 210 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
• TABLE 211 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 212 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 213 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• TABLE 214 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 215 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
• TABLE 216 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.3.3 UK
  • 12.3.3.1 Increasing pet ownership to drive market
• TABLE 217 UK: HOUSEHOLDS WITH PETS (2022)
• TABLE 218 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 219 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
• TABLE 220 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 221 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 222 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 223 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 224 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 225 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 226 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 227 UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 228 UK: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 229 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
• TABLE 230 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 231 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 232 UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• TABLE 233 UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 234 UK: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
• TABLE 235 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.3.4 FRANCE
  • 12.3.4.1 Willingness of pet owners to spend on pet health to drive market
• TABLE 236 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 237 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
• TABLE 238 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 239 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 240 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 241 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 242 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 243 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 244 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 245 FRANCE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 246 FRANCE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 247 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
• TABLE 248 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 249 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 250 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• TABLE 251 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 252 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
• TABLE 253 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.3.5 ITALY
  • 12.3.5.1 Rising awareness about pet healthcare to propel market growth
• TABLE 254 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 255 ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
• TABLE 256 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 257 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 258 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 259 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 260 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 261 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 262 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 263 ITALY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 264 ITALY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 265 ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
• TABLE 266 ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 267 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 268 ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• TABLE 269 ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 270 ITALY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
• TABLE 271 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.3.6 SPAIN
  • 12.3.6.1 Growing demand for pig and poultry products to aid adoption of veterinary diagnostic products
• TABLE 272 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 273 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
• TABLE 274 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 275 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 276 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 277 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 278 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 279 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 280 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 281 SPAIN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 282 SPAIN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 283 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
• TABLE 284 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 285 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 286 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• TABLE 287 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 288 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
• TABLE 289 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.3.7 REST OF EUROPE
• TABLE 290 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 291 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
• TABLE 292 REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 293 REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 294 REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 295 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 296 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 297 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 298 REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 299 REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 300 REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
• TABLE 301 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
• TABLE 302 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 303 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 304 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
• TABLE 305 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
• TABLE 306 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
• TABLE 307 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.4 ASIA PACIFIC
  • 12.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 50 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
  • TABLE 308 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 313 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 314 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 326 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.4.2 CHINA
    • 12.4.2.1 Large pool of food-producing animals in China to drive market
  • TABLE 327 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 328 CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 329 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 330 CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 331 CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 332 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 333 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 334 CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 335 CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 336 CHINA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 337 CHINA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 338 CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 339 CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 340 CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 341 CHINA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 342 CHINA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 343 CHINA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 344 CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.4.3 JAPAN
    • 12.4.3.1 Rising awareness about zoonotic diseases and increased pet expenditure to support adoption
  • FIGURE 51 JAPAN: FOOD, SNACK, AND MEDICAL EXPENDITURE FOR CATS AND DOGS (USD)
  • TABLE 345 NUMBER OF DOMESTICATED DOGS AND CATS IN JAPAN, 2012-2020 (THOUSAND)
  • TABLE 346 PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 347 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 348 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 349 JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 350 JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 351 JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 352 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 353 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 354 JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 355 JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 356 JAPAN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 357 JAPAN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 358 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 359 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 360 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 361 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 362 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 363 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 364 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.4.4 INDIA
    • 12.4.4.1 Growing demand for livestock products to support market growth
  • TABLE 365 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 366 INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 367 INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 368 INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 369 INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 370 INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 371 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 372 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 373 INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 374 INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 375 INDIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 376 INDIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 377 INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 378 INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 379 INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 380 INDIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 381 INDIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 382 INDIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 383 INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Increase in pet ownership will support market growth
  • TABLE 384 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 385 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 386 AUSTRALIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 387 AUSTRALIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 388 AUSTRALIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 389 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 390 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 391 AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 392 AUSTRALIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 393 AUSTRALIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 394 AUSTRALIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 395 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 396 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 397 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 398 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 399 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 400 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 401 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 Growing companion animal population to drive market
  • TABLE 402 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 403 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 404 SOUTH KOREA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 405 SOUTH KOREA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 406 SOUTH KOREA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 407 SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 408 SOUTH KOREA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 409 SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 410 SOUTH KOREA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 411 SOUTH KOREA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 412 SOUTH KOREA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 413 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 414 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 415 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 416 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 417 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 418 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 419 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.4.7 REST OF ASIA PACIFIC
  • TABLE 420 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 421 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 422 REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 423 REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 424 REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 425 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 426 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 427 REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 428 REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 429 REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 430 REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 431 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 432 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 433 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 434 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 435 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 436 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 437 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
• 12.5 LATIN AMERICA
  • TABLE 438 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010-2022 (MILLION)
  • 12.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 439 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 440 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 441 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 442 LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 443 LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 444 LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 445 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 446 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 447 LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 448 LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 449 LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 450 LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 451 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 452 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 453 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 454 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 455 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 457 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.5.2 BRAZIL
    • 12.5.2.1 Well-established and rapidly growing livestock industry in Brazil to promote growth
  • TABLE 458 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 459 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 460 BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 461 BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 462 BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 463 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 464 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 465 BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 466 BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 467 BRAZIL: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 468 BRAZIL: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 469 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 470 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 471 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 472 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 473 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 474 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 475 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.5.3 MEXICO
    • 12.5.3.1 Mexico to retain second-largest share in Latin America till 2029
  • TABLE 476 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 477 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029(USD MILLION)
  • TABLE 478 MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 479 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 480 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 481 MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 482 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 483 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 484 MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 485 MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 486 MEXICO: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 487 MEXICO: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 488 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 489 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 490 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 491 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 492 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 493 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 494 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)
  • 12.5.4 REST OF LATIN AMERICA
  • TABLE 495 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 496 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 497 REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 498 REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 499 REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 500 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 501 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 502 REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 503 REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 504 REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 505 REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 506 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 507 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 508 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 509 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 510 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 511 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 512 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)

• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 LOW PORK PRODUCTION AND CONSUMPTION IN MIDDLE EASTERN COUNTRIES DUE TO RELIGIOUS CUSTOMS TO LIMIT GROWTH
  • 12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 513 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 514 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
  • TABLE 515 MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 516 MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 517 MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 518 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 519 MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 520 MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 521 MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 522 MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 523 MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • TABLE 524 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
  • TABLE 525 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 526 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 527 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
  • TABLE 528 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 529 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
  • TABLE 530 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021-2029 (USD MILLION)

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 13.3 REVENUE ANALYSIS
  • FIGURE 52 REVENUE ANALYSIS FOR KEY COMPANIES IN PAST FIVE YEARS
• 13.4 MARKET SHARE ANALYSIS
  • FIGURE 53 VETERINARY DIAGNOSTICS MARKET: MARKET SHARE ANALYSIS, 2022
• 13.5 COMPANY EVALUATION MATRIX
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • FIGURE 54 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022
  • 13.5.5 COMPANY FOOTPRINT
  • TABLE 531 PRODUCT FOOTPRINT
  • TABLE 532 TECHNOLOGY FOOTPRINT
  • TABLE 533 END-USER FOOTPRINT
  • TABLE 534 REGION FOOTPRINT
  • TABLE 535 COMPANY FOOTPRINT
• 13.6 START-UP/SME EVALUATION MATRIX
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 DYNAMIC COMPANIES
  • 13.6.3 STARTING BLOCKS
  • 13.6.4 RESPONSIVE COMPANIES
  • FIGURE 55 VETERINARY DIAGNOSTICS MARKET: START-UP/SME EVALUATION MATRIX (2022)
  • 13.6.5 COMPETITIVE BENCHMARKING
• 13.7 COMPETITIVE SCENARIO
  • 13.7.1 PRODUCT LAUNCHES
  • TABLE 536 PRODUCT LAUNCHES
  • 13.7.2 DEALS
  • TABLE 537 DEALS
  • 13.7.3 OTHER DEVELOPMENTS
  • TABLE 538 OTHER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
• (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 14.1.1 IDEXX LABORATORIES, INC.
• TABLE 539 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
• FIGURE 56 IDEXX LABORATORIES: COMPANY SNAPSHOT (2022)
• 14.1.2 ZOETIS, INC.
• TABLE 540 ZOETIS, INC.: COMPANY OVERVIEW
• FIGURE 57 ZOETIS, INC.: COMPANY SNAPSHOT (2022)
• 14.1.3 THERMO FISHER SCIENTIFIC, INC.
• TABLE 541 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
• FIGURE 58 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (20222)
• 14.1.4 HESKA CORPORATION (MARS INCORPORATED)
• TABLE 542 HESKA CORPORATION: COMPANY OVERVIEW
• FIGURE 59 HESKA CORPORATION: COMPANY SNAPSHOT (2022)
• 14.1.5 BIOMERIEUX SA
• TABLE 543 BIOMERIEUX SA: COMPANY OVERVIEW
• FIGURE 60 BIOMERIEUX SA: COMPANY SNAPSHOT (2022)
• 14.1.6 NEOGEN CORPORATION
• TABLE 544 NEOGEN CORPORATION: COMPANY OVERVIEW
• FIGURE 61 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
• 14.1.7 BIO-RAD LABORATORIES, INC.
• TABLE 545 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
• FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
• 14.1.8 VIRBAC
• TABLE 546 VIRBAC: COMPANY OVERVIEW
• FIGURE 63 VIRBAC: COMPANY SNAPSHOT (2022)
• 14.1.9 FUJIFILM HOLDINGS CORPORATION
• TABLE 547 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
• FIGURE 64 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
• 14.1.10 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
• TABLE 548 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
• FIGURE 65 MINDRAY GROUP: COMPANY SNAPSHOT (2022)
• 14.1.11 INDICAL BIOSCIENCE GMBH
• TABLE 549 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
• 14.1.12 BIONOTE INC.
• TABLE 550 BIONOTE INC.: COMPANY OVERVIEW
• 14.1.13 BIOGAL GALED LABS
• TABLE 551 BIOGAL GALED LABS: COMPANY OVERVIEW
• 14.1.14 AGROLABO S.P.A.
• TABLE 552 AGROLABO S.P.A.: COMPANY OVERVIEW
• 14.1.15 INNOVATIVE DIAGNOSTICS
• TABLE 553 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
• 14.2 OTHER PLAYERS
  • 14.2.1 RANDOX LABORATORIES LTD.
  • 14.2.2 BIOCHEK
  • 14.2.3 FASSISI GMBH
  • 14.2.4 ALVEDIA
  • 14.2.5 SKYER, INC.
  • 14.2.6 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
  • 14.2.7 PRECISION BIOSENSOR
  • 14.2.8 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
  • 14.2.9 GOLD STANDARD DIAGNOSTICS
  • 14.2.10 ANTECH DIAGNOSTICS, INC.
• *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

관련자료